Oral Communications

About this session

Oral communications: OC54 Amyloid and Tau PET Biological Staging Across Ethnoracial Groups in a Multi-Cohort Alzheimer's Disease Study; OC55 Biomarker Associations and Outcome Performance in Preclinical Alzheimer Disease Trials; OC56 [18F]MODAG-009 PET imaging of alpha-synuclein pathology in the presence of amyloid-beta and tau co-pathology across the AD-DLB spectrum; OC57 Cross-platform performance of plasma p-tau217 assays for predicting amyloid PET positivity across cohorts; OC58 Plasma %p-tau217 and Aβ42/Aβ40 provide complementary information about amyloid PET below 20 Centiloids: Baseline findings from the Alzheimer's Plasma Extension Study.

Speakers

• DM

  Doris Molina-Henry

  USC Keck School of Medicine, ATRI

  Chair

• MD

  Mike Donohue

  USC Epstein Family Alzheimer's Therapeutic Research Institute

  Chair